IQV | IQVIA Holdings Inc.

Healthcare | Diagnostics & Research | USA | NYSE

Index	S&P 500	P/E	37.09	EPS (ttm)	5.57	Insider Own	0.88%	Shs Outstand	185.80M	Perf Week	2.59%
Market Cap	37.88B	Forward P/E	17.28	EPS next Y	11.96	Insider Trans	-0.69%	Shs Float	184.29M	Perf Month	9.84%
Income	1.05B	PEG	3.21	EPS next Q	2.37	Inst Own	91.10%	Short Float / Ratio	1.08% / 1.64	Perf Quarter	4.73%
Sales	14.49B	P/S	2.61	EPS this Y	15.50%	Inst Trans	0.41%	Short Interest	2.00M	Perf Half Y	-0.53%
Book/sh	31.93	P/B	6.47	EPS next Y	14.78%	ROA	4.20%	Target Price	243.89	Perf Year	-6.40%
Cash/sh	8.72	P/C	23.70	EPS next 5Y	11.55%	ROE	18.80%	52W Range	165.75 - 249.11	Perf YTD	0.83%
Dividend	-	P/FCF	25.12	EPS past 5Y	32.60%	ROI	8.20%	52W High	-17.07%	Beta	1.39
Dividend %	-	Quick Ratio	0.80	Sales past 5Y	8.20%	Gross Margin	34.80%	52W Low	24.64%	ATR	4.51
Employees	87000	Current Ratio	0.80	Sales Q/Q	2.40%	Oper. Margin	12.20%	RSI (14)	63.15	Volatility	1.74% 2.17%
Optionable	Yes	Debt/Eq	2.22	EPS Q/Q	-8.80%	Profit Margin	7.30%	Rel Volume	0.80	Prev Close	206.19
Shortable	Yes	LT Debt/Eq	1.99	Earnings	Apr 27 BMO	Payout	0.00%	Avg Volume	1.22M	Price	206.59
Recom	1.70	SMA20	4.15%	SMA50	5.34%	SMA200	0.64%	Volume	973,479	Change	0.19%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-17-23	Initiated	Truist	Buy	$265
Dec-06-22	Initiated	Cowen	Outperform	$251
Nov-17-22	Downgrade	Citigroup	Buy → Neutral	$275 → $245
Aug-25-22	Initiated	Credit Suisse	Outperform	$300
Jul-15-22	Initiated	SVB Leerink	Outperform	$256
May-24-22	Initiated	Guggenheim	Buy	$244
Apr-29-22	Upgrade	Piper Sandler	Neutral → Overweight	$231 → $255
Apr-25-22	Downgrade	Wells Fargo	Overweight → Equal Weight	$235
Aug-05-21	Resumed	Credit Suisse	Outperform	$272
Apr-16-21	Upgrade	Stephens	Equal-Weight → Overweight	$180 → $250
Mar-08-21	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$218
Mar-03-21	Initiated	Barclays	Overweight	$220
Jul-07-20	Initiated	Stephens	Equal-Weight	$150
Mar-02-20	Initiated	Deutsche Bank	Buy	$190
Jan-08-20	Initiated	Wells Fargo	Overweight	$180
Jan-07-20	Initiated	Citigroup	Buy	$185
Dec-13-19	Upgrade	CFRA	Sell → Hold
Nov-14-19	Upgrade	Wolfe Research	Peer Perform → Outperform
Jun-21-19	Upgrade	Mizuho	Neutral → Buy	$150 → $175
May-28-19	Initiated	SVB Leerink	Outperform

Show Previous Ratings

Jun-07-23 12:07PM	Why You Should Retain IQVIA Holdings (IQV) Stock for Now (Zacks)
Jun-02-23 05:27AM	Is Veeva Systems a Buy Now? (Motley Fool)
May-27-23 12:22PM	Billionaire Stanley Druckenmillers 2023 Portfolio: Top 10 Stock Picks (Insider Monkey)
May-25-23 04:03AM	14 Best Biotech Stocks To Buy According To Hedge Funds (Insider Monkey)
02:00AM	IQVIA & (RED) Announce Groundbreaking Partnership to Support Laboratory System Strengthening (Business Wire)
08:00AM	Loading…
May-24-23 08:00AM	Global Oncology R&D Activity Remains High and More Patients Have Been Treated for Cancer, says IQVIA Institute for Human Data Science (Business Wire)
May-23-23 12:40PM	IQVIA's (IQV) Extensive Database Blocks New Entrants (Zacks)
May-18-23 04:38PM	IQVIA Announces Pricing of Upsized Offering of Senior Secured Notes and Senior Notes (Business Wire)
08:25AM	IQVIA Announces Offering of Senior Secured Notes and Senior Notes (Business Wire)
May-11-23 11:00AM	IQVIA Celebrates Sheetal Telang, Winner of Healthcare Businesswoman's Association Rising Star Award (Business Wire)
May-08-23 08:26AM	Zacks Industry Outlook Highlights Trane Technologies, IQVIA Holdings and TuSimple Holdings (Zacks)
May-05-23 12:05PM	3 Stocks to Watch From a Promising Technology Services Industry (Zacks)
May-03-23 12:06AM	Q1 2023 Incyte Corp Earnings Call (Thomson Reuters StreetEvents)
May-02-23 08:00AM	Use of Medicines in the U.S. Continued to Grow in 2022 while Patient Out-of-Pocket Costs Remain Low, Says IQVIA Institute (Business Wire)
Apr-27-23 01:31PM	IQVIA Holdings (IQV) Surpasses Q1 Earnings & Revenue Estimates (Zacks)
08:15AM	Loading…
08:15AM	IQVIA Holdings (IQV) Tops Q1 Earnings and Revenue Estimates (Zacks)
07:00AM	IQVIA Reports First-Quarter 2023 Results; Reaffirms Full-Year 2023 Guidance (Business Wire)
Apr-25-23 12:55PM	IQVIA (IQV) to Report Q1 Earnings: What's in the Cards? (Zacks) -5.56%
Apr-20-23 11:00AM	IQVIA Named a Leader in Everest Group Life Sciences Customer Experience Platforms PEAK Matrix® Assessment 2023 (Business Wire)
Apr-11-23 12:31PM	Here's Why Investors Should Retain IQVIA Holdings (IQV) Stock (Zacks)
Apr-06-23 04:15PM	IQVIA to Announce First-Quarter 2023 Results on April 27, 2023 (Business Wire)
Mar-28-23 12:56PM	Analyst Report: IQVIA Holdings Inc (Argus Research)
12:41PM	Market Update: KO, IQV (Argus Research)
Mar-25-23 07:20AM	2 Clinical Research Stocks That Could Grow by More Than 10% This Year, and 1 to Watch (Motley Fool)
Mar-14-23 08:00AM	Global Clinical Trial Activity Remained Resilient in 2022 Despite The Continued Pandemic, Says IQVIA Institute (Business Wire)
Mar-13-23 02:39PM	IQVIA Holdings (NYSE:IQV) sheds 10% this week, as yearly returns fall more in line with earnings growth (Simply Wall St.)
Mar-02-23 08:29PM	Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-01-23 04:15PM	IQVIA CFO Ron Bruehlman to Speak at Barclays Global Healthcare Conference on March 15, 2023 (Business Wire)
Feb-27-23 12:51PM	Should You Be Excited About IQVIA Holdings Inc.'s (NYSE:IQV) 19% Return On Equity? (Simply Wall St.)
07:56AM	Weekly Stock List (Argus Research)
11:00AM	Loading…
Feb-23-23 11:00AM	IQVIA Publishes its 2022 Environmental, Social and Governance Report (Business Wire)
Feb-21-23 06:48PM	Biosimilars Were Supposed to Tame Costs for Drugs Like Humira. It Isnt Working. (Barrons.com)
05:16AM	Got $300? 3 Growth Stocks to Buy That Could Double Your Money (Motley Fool)
Feb-16-23 02:45PM	Iqvia leaves prominent Durham tower (American City Business Journals)
Feb-15-23 02:11PM	7 Hot Healthcare Stocks With the Potential to Outperform (InvestorPlace)
Feb-13-23 02:34PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
11:43AM	Fidelity National (FIS) Q4 Earnings Beat on Banking Business (Zacks)
Feb-12-23 07:35AM	IQVIA Holdings Full Year 2022 Earnings: EPS Misses Expectations (Simply Wall St.)
Feb-10-23 11:32AM	IQVIA (IQV) Q4 Earnings and Revenues Beat Mark, Rise Y/Y (Zacks)
08:59AM	IQVIA Clocks 2.8% Sales Growth In Q4, Beats Street View By A Whisker (Benzinga)
08:25AM	IQVIA Holdings (IQV) Beats Q4 Earnings and Revenue Estimates (Zacks)
07:00AM	IQVIA Reports Fourth-Quarter and Full-Year 2022 Results; Issues Full-Year 2023 Guidance (Business Wire)
Feb-09-23 12:00PM	IQVIA Named to FORTUNEs 2023 List of "Worlds Most Admired Companies," Ranked #1 in Its Category for the Second Consecutive Year (Business Wire)
Feb-07-23 09:53AM	3 Revolutionary Stocks I'd Buy Right Now Without Hesitation (Motley Fool)
Feb-06-23 01:34PM	IQVIA (IQV) to Report Q4 Earnings: What's in the Cards? (Zacks)
Feb-03-23 10:00AM	IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy? (Zacks)
08:35AM	At US$241, Is IQVIA Holdings Inc. (NYSE:IQV) Worth Looking At Closely? (Simply Wall St.)
Jan-31-23 09:59AM	IQVIA in Collaboration with Alibaba Cloud to Deliver Commercial & Clinical Solutions in China (Business Wire)
Jan-30-23 05:25PM	Symbotic Inc. (SYM) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
Jan-25-23 05:35PM	Seagate (STX) Q2 Earnings and Revenues Surpass Estimates (Zacks)
04:15PM	IQVIA to Announce Fourth-Quarter and Full-Year 2022 Results on February 10, 2023 (Business Wire)
Jan-20-23 08:25AM	Here's Why IQVIA Holdings (NYSE:IQV) Has Caught The Eye Of Investors (Simply Wall St.)
Jan-18-23 12:26PM	Global Market for Medicines to Rise to $1.9 Trillion by 2027, says Report from IQVIA Institute (Business Wire)
Jan-11-23 08:44AM	2 Unstoppable Growth Stocks to Buy in 2023 and Beyond (Motley Fool)
07:39AM	Judge rules Iqvia's noncompete lawsuit can continue as FTC pushes ban (American City Business Journals)
Jan-06-23 07:00AM	IQVIA Holdings Inc. (NYSE:IQV) is largely controlled by institutional shareholders who own 89% of the company (Simply Wall St.)
05:51AM	IQVIA (IQV) Gains 10.4% in the Past 3 Months: Here's Why (Zacks)
Jan-05-23 02:08PM	Labcorp names Thomas Pike as president and CEO of clinical development business spin-off (American City Business Journals)
02:27AM	Instructure (INST) Surges 7.9%: Is This an Indication of Further Gains? (Zacks)
Jan-03-23 11:05AM	Lasso announces a significant step forward in healthcare marketing measurement (PR Newswire)
Jan-02-23 07:34AM	Is IQVIA Holdings Inc. (NYSE:IQV) Trading At A 27% Discount? (Simply Wall St.)
Dec-28-22 08:30AM	Biostage Selects IQVIA to Manage its FDA-Approved Clinical Trial in Severe Esophageal Disease, including Cancer (PR Newswire)
Dec-20-22 09:45AM	Why IQVIA Holdings (IQV) is a Top Growth Stock for the Long-Term (Zacks)
Dec-08-22 02:13PM	Do You Think IQVIA Holdings (IQV) is a Worthy Investment? (Insider Monkey)
11:31AM	Why Is ADTRAN Holdings (ADTN) Up 4.7% Since Last Earnings Report? (Zacks)
Dec-02-22 11:31AM	Why Is Trane Technologies (TT) Up 8.1% Since Last Earnings Report? (Zacks)
Nov-25-22 11:31AM	Why Is IQVIA (IQV) Up 8.6% Since Last Earnings Report? (Zacks)
Nov-14-22 07:19AM	Zacks Industry Outlook Highlights IQVIA Holdings, Matterport and TuSimple Holdings (Zacks)
Nov-11-22 11:47AM	3 Technology Services Stocks to Watch From a Promising Industry (Zacks)
Nov-10-22 11:00AM	IQVIA and Clalit Health Services partner to advance research by launching the first Prime Site in Israel (Business Wire) +8.94%
Oct-27-22 02:49PM	Mastercard's (MA) Q3 Earnings Beat Estimates on Better GDV (Zacks)
Oct-26-22 03:25PM	IQVIA (IQV) Q3 Earnings and Revenues Beat Mark, Rise Y/Y (Zacks)
08:25AM	IQVIA Holdings (IQV) Q3 Earnings and Revenues Top Estimates (Zacks)
07:00AM	IQVIA Reports Third-Quarter 2022 Results (Business Wire)
Oct-24-22 04:15PM	IQVIA CFO Ron Bruehlman to Speak at Credit Suisse Annual Healthcare Conference on November 8, 2022 (Business Wire)
Oct-20-22 02:12PM	IQVIA (IQV) to Report Q3 Earnings: What's in the Cards? (Zacks)
Oct-19-22 10:01AM	IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy? (Zacks)
Oct-18-22 01:01PM	With 89% ownership of the shares, IQVIA Holdings Inc. (NYSE:IQV) is heavily dominated by institutional owners (Simply Wall St.)
Oct-12-22 07:22AM	Here's Why You Should Invest in IQVIA Holdings (IQV) Now (Zacks)
Oct-11-22 02:45PM	Mastercard's (MA) Platform to Simplify Global Business Payments (Zacks)
09:35AM	IQVIA (IQV) Loses 22.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Oct-10-22 11:40AM	IQV vs. CLBT: Which Stock Is the Better Value Option? (Zacks)
09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Oct-07-22 09:01AM	10 Best Fast Money Stocks To Buy According To Hedge Funds (Insider Monkey)
Oct-06-22 08:15AM	Q² Solutions Launches Innovative Self-Collection Safety Lab Panel in Collaboration With Tasso (Business Wire)
Oct-04-22 11:46AM	Those who invested in IQVIA Holdings (NYSE:IQV) five years ago are up 94% (Simply Wall St.)
Oct-03-22 04:15PM	IQVIA to Announce Third-Quarter 2022 Results on October 26, 2022 (Business Wire)
Sep-30-22 03:07PM	Durham giant Iqvia drops one lawsuit against ex-VP while another continues (American City Business Journals)
Sep-28-22 10:00AM	IQVIA Decentralized Clinical Trial Program Achieves Independent GDPR Validation (Business Wire)
Sep-23-22 05:12PM	Paychex (PAYX) to Report Q1 Earnings: What's in the Cards? (Zacks)
09:41AM	10 Best Stocks to Buy Now According to Billionaire Thomas Steyer (Insider Monkey)
Sep-22-22 08:05AM	Accenture (ACN) Beats Q4 Earnings Estimates (Zacks)
Sep-20-22 04:31PM	What's in the Offing for Accenture (ACN) in Q4 Earnings? (Zacks)
02:30PM	How Raleigh, Triangle lost its most prominent public companies (American City Business Journals)
11:30AM	Is IQVIA Holdings Inc.'s (NYSE:IQV) ROE Of 22% Impressive? (Simply Wall St.)
Sep-19-22 10:06AM	FactSet (FDS) to Report Q4 Earnings: What's in the Offing? (Zacks)
Sep-16-22 05:59PM	Here's Why a Hold Strategy is Apt for IQVIA (IQV) Stock (Zacks)
Sep-07-22 08:15AM	New IQVIA Study Demonstrates Cost and Time Savings of Decentralized Trials (Business Wire)
Sep-06-22 10:36AM	Insiders who placed huge bets on IQVIA Holdings Inc. (NYSE:IQV) earlier this year would be disappointed with the 5.0% drop (Simply Wall St.)
Sep-05-22 08:35AM	DocuSign (DOCU) to Report Q2 Earnings: What's in the Offing? (Zacks)

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and decentralized clinical trials, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was incorporated in 2016 and is headquartered in Durham, North Carolina.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Knightly Kevin C	See Remarks	Jun 05	Sale	201.89	5,820	1,175,000	0	Jun 07 05:31 PM
Knightly Kevin C	See Remarks	May 26	Sale	198.66	1	199	0	May 31 09:29 PM
Knightly Kevin C	See Remarks	Feb 16	Sale	225.61	4,446	1,003,068	1,973	Feb 17 05:13 PM
Sherbet Eric	See Remarks	Feb 14	Sale	230.00	1,000	230,000	17,053	Feb 15 05:58 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

IQV | IQVIA Holdings Inc.

Upgrade your FINVIZ experience